Outcomes After Early Pregnancy Loss Management With Mifepristone Plus Misoprostol vs Misoprostol Alone
The findings of this study suggest that mifepristone is underutilized for the medication management of EPL, but its use is associated with a lower need for subsequent uterine aspiration and a decrease in the number of subsequent visits to an ED. Increasing access to mifepristone for EPL management may decrease health care utilization and expenditures.
Authors
- John L. Gore (ORCID: https://orcid.org/0000-0002-2847-5062)
- Sarah K. Holt (ORCID: https://orcid.org/0000-0001-6302-5502)
- Vanessa K. Dalton
- Lyndsey S. Benson (ORCID: https://orcid.org/0000-0003-2029-0087)
- Navya Gunaje
Institutions
- University of Washington (US)
- University of Michigan (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2024-10-08
- DOI
- https://doi.org/10.1001/jamanetworkopen.2024.35906
- Citations
- 7
- Primary Topic
- Reproductive Health and Contraception
- Type
- article
- Field-Weighted Citation Impact
- 3.80
Funders
- National Institutes of Health